共 50 条
- [42] ASSOCIATION OF IMMUNE-RELATED ADVERSE EVENTS WITH PROGNOSIS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB JOURNAL OF UROLOGY, 2019, 201 (04): : E71 - E71
- [45] Relation of overall tumor burden with severe immune-related adverse events in nivolumab plus ipilimumab treatment for lung cancer Investigational New Drugs, 2022, 40 : 1315 - 1321
- [48] Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab PLOS ONE, 2019, 14 (05):